DOUBLE-BLIND, CROSSOVER PLACEBO CONTROLLED TRIAL OF SELEGILINE IN PARKINSONS-DISEASE - AN INTERIM ANALYSIS

被引：11
|
作者：
TEYCHENNE, PF
PARKER, S
机构：
[1] BALMAIN HOSP,SYDNEY,AUSTRALIA
[2] ROZELLO HOSP,SYDNEY,AUSTRALIA
[3] RECKITT & COLMAN PHARMACEUT,W RYDE,NSW,AUSTRALIA
[4] NEW S WALES INST PSYCHIAT,SYDNEY,NSW,AUSTRALIA
来源：
ACTA NEUROLOGICA SCANDINAVICA | 1989年 / 80卷
关键词：
D O I：
10.1111/j.1600-0404.1989.tb01791.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：119 / 125
页数：7
相关论文
共 50 条
  • [1] MESULERGINE IN EARLY PARKINSONS-DISEASE - A DOUBLE-BLIND CONTROLLED TRIAL
    DUPONT, E
    MIKKELSEN, B
    JAKOBSEN, J
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (04): : 390 - 395
  • [2] SELEGILINE (1-DEPRENYL) AND LOW-DOSE LEVODOPA TREATMENT OF PARKINSONS-DISEASE - A DOUBLE-BLIND CROSSOVER TRIAL
    PRESTHUS, J
    BERSTAD, J
    LIEN, K
    ACTA NEUROLOGICA SCANDINAVICA, 1987, 76 (03): : 200 - 203
  • [3] DOUBLE-BLIND TRIAL OF BROMOCRIPTINE IN PARKINSONS-DISEASE
    MACKENZIE, RA
    LANCE, JW
    MEDICAL JOURNAL OF AUSTRALIA, 1978, 2 : 27 - 28
  • [4] DOUBLE-BLIND TRIAL OF PERGOLIDE FOR PARKINSONS-DISEASE
    DIAMOND, SG
    MARKHAM, CH
    TRECIOKAS, LJ
    NEUROLOGY, 1985, 35 (03) : 291 - 295
  • [5] PERGOLIDE THERAPY IN PARKINSONS-DISEASE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    SAGE, JI
    DUVOISIN, RC
    CLINICAL NEUROPHARMACOLOGY, 1985, 8 (03) : 260 - 265
  • [6] ADJUVANT TREATMENT OF PARKINSONS-DISEASE WITH BUDIPINE - A DOUBLE-BLIND TRIAL VERSUS PLACEBO
    JELLINGER, K
    BLIESATH, H
    JOURNAL OF NEUROLOGY, 1987, 234 (05) : 280 - 282
  • [7] A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF PERGOLIDE AS AN ADJUNCT TO SINEMET(R) IN PARKINSONS-DISEASE
    OLANOW, CW
    FAHN, S
    MUENTER, M
    KLAWANS, H
    HURTIG, H
    STERN, M
    SHOULSON, I
    KURLAN, R
    GRIMES, JD
    JANKOVIC, J
    HOEHN, M
    MARKHAM, CH
    DUVOISIN, R
    REINMUTH, O
    LEONARD, HA
    AHLSKOG, E
    FELDMAN, R
    HERSHEY, L
    YAHR, MD
    MOVEMENT DISORDERS, 1994, 9 (01) : 40 - 47
  • [8] SELEGILINE (L-DEPRENYL) AND L-DOPA TREATMENT OF PARKINSONS-DISEASE - A DOUBLE-BLIND TRIAL
    TAKAHASHI, M
    YUASA, R
    IMAI, T
    TACHIBANA, H
    YORIFUJI, S
    NAKAMURA, Y
    OGAWA, N
    INTERNAL MEDICINE, 1994, 33 (09) : 517 - 524
  • [9] A DOUBLE-BLIND CROSSOVER PLACEBO CONTROLLED TRIAL OF XIMOPROFEN IN AS
    DOUGADOS, M
    CAPORAL, R
    DOURY, P
    THIESCE, A
    PATTIN, S
    LAFFEZ, B
    AMOR, B
    JOURNAL OF RHEUMATOLOGY, 1989, 16 (08) : 1167 - 1169
  • [10] AMANTADINE IN PARKINSONS-DISEASE - DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY WITH LONG-TERM FOLLOW-UP
    BUTZER, JF
    SILVER, DE
    SAHS, AL
    NEUROLOGY, 1975, 25 (07) : 603 - 606
12345